Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Malignant Melanoma

Free Subscription 01.04.2024 1 Ann Surg Oncol 1 BMC Cancer 2 J Am Acad Dermatol 1 J Biol Chem 1 J Surg Oncol 1 Melanoma Res 1 Oncogene 3 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Surg Oncol

1. LEE TS, Spillane AJ
   ASO Author Reflections: Lymphoedema Related to Inguinal and Ilioinguinal Lymphadenectomy for Melanoma.
   Ann Surg Oncol. 2024 Mar 27. doi: 10.1245/s10434-024-15216.
   PubMed        
   
   

   
   BMC Cancer

2. WHITMAN ED, Totev TI, Jiang S, da Costa WL Jr, et al
   Assessing the use of anti-PD1 monotherapy as adjuvant therapy and determinants of treatment choice in stage III cutaneous melanoma in the US.
   BMC Cancer. 2024;24:389.
   PubMed         Abstract available
   
   

   
   J Am Acad Dermatol

3. WANG E, Ahad T, Liu YA, Lee TK, et al
   Incidence and profile of skin cancers in patients following ultraviolet phototherapy without psoralens: A retrospective cohort study.
   J Am Acad Dermatol. 2024;90:759-766.
   PubMed         Abstract available
   
   
4. COHEN Y, Jaberi M, Litvinov IV, Shamout Y, et al
   Novel suturing technique for reduced electrocautery in excisional procedures for non-melanoma skin cancer.
   J Am Acad Dermatol. 2024;90:e131-e132.
   PubMed        
   
   

   
   J Biol Chem

5. LEE YH, Yoon AR, Yun CO, Chung KC, et al
   Dual-specificity kinase DYRK3 phosphorylates p62 at the Thr-269 residue and promotes melanoma progression.
   J Biol Chem. 2024 Mar 20:107206. doi: 10.1016/j.jbc.2024.107206.
   PubMed         Abstract available
   
   

   
   J Surg Oncol

6. EMILE SH, Horesh N, Garoufalia Z, Gefen R, et al
   A national database analysis of the evolution of outcomes of surgery for anal melanoma.
   J Surg Oncol. 2024 Mar 27. doi: 10.1002/jso.27631.
   PubMed         Abstract available
   
   

   
   Melanoma Res

7. FABRE M, Lamoureux A, Meunier L, Samaran Q, et al
   Efficiency and tolerance of second-line triple BRAF inhibitor/MEK inhibitor/anti-PD1 combined therapy in BRAF mutated melanoma patients with central nervous system metastases occurring during first-line combined targeted therapy: a real-life survey.
   Melanoma Res. 2024 Mar 28. doi: 10.1097/CMR.0000000000000963.
   PubMed         Abstract available
   
   

   
   Oncogene

8. DURAND S, Tang Y, Pommier RM, Benboubker V, et al
   ZEB1 controls a lineage-specific transcriptional program essential for melanoma cell state transitions.
   Oncogene. 2024 Mar 22. doi: 10.1038/s41388-024-03010.
   PubMed         Abstract available
   
   

   
   PLoS One

9. JEONG H, Cho YR, Gim J, Cha SK, et al
   GraphMHC: Neoantigen prediction model applying the graph neural network to molecular structure.
   PLoS One. 2024;19:e0291223.
   PubMed         Abstract available
   
   
10. 
    Retraction: Dermokine mutations contribute to epithelial-mesenchymal transition and advanced melanoma through ERK/MAPK pathways.
    PLoS One. 2024;19:e0300807.
    PubMed        
    
    
11. ALSHAHRANI M, Al-Jabbar M, Senan EM, Ahmed IA, et al
    Analysis of dermoscopy images of multi-class for early detection of skin lesions by hybrid systems based on integrating features of CNN models.
    PLoS One. 2024;19:e0298305.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge.